Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Apr
2
2021
FDA Continues to Referee the CBD Market Dinsmore & Shohl LLP
Apr
2
2021
Cannabis Banking; The SAFE Banking Act 2.0's Status, Key Modifications, and Prospects K&L Gates
Apr
2
2021
New York Legalizes Recreational Marijuana Jackson Lewis P.C.
Apr
1
2021
FDA Reissues Notice Announcing Increased OTC Monograph Facility Fees Womble Bond Dickinson (US) LLP
Apr
1
2021
Court Blocks New Acrylamide Lawsuits Under Prop 65 Keller and Heckman LLP
Mar
31
2021
Tax Issues and the New York Marijuana Regulation and Taxation Act Greenberg Traurig, LLP
Mar
31
2021
New York State Legalizes Recreational Adult Use of Marijuana Proskauer Rose LLP
Mar
31
2021
340B in 2021: What Covered Entities and Their Partners Need to Know Now Recap McDermott Will & Emery
Mar
31
2021
Congressmembers Introduce The Baby Food Safety Act Keller and Heckman LLP
Mar
30
2021
SOT FDA Colloquia Series Will Include Webcast on the Toxicology of Nanoparticles Bergeson & Campbell, P.C.
Mar
30
2021
Proposed NY Marijuana Regulation and Taxation Act to Legalize, Tax, and Regulate Adult-Use Cannabis Greenberg Traurig, LLP
Mar
30
2021
Biden’s Nominee to the Fed. Cir. is Perkins Coie Litigator
Mar
30
2021
New York to Join in the Legalization of Adult-Use Cannabis Womble Bond Dickinson (US) LLP
Mar
30
2021
Vanilla Flavoring Class Action Lawsuit Against McDonald’s Dismissed Keller and Heckman LLP
Mar
29
2021
FDA Announces First Ever Facility Fees for OTC Drug Manufacturers Sheppard, Mullin, Richter & Hampton LLP
Mar
29
2021
Exemptions Limited for Juice Preventive Controls Keller and Heckman LLP
Mar
26
2021
Online Cannabis Marketplace Businessmen Convicted of Conspiracy to Commit Bank Fraud Sheppard, Mullin, Richter & Hampton LLP
Mar
26
2021
Dairy Alternative Labeling Debate Continues Keller and Heckman LLP
Mar
26
2021
Bucks County, PA Doctor Charged for Running Illegal “Pill Mill” Stark & Stark
Mar
26
2021
Second Prop 65 Amendment Effective April 1, 2021: New Warnings Required McDermott Will & Emery
Mar
26
2021
How Safe is CBD? Keller and Heckman LLP
Mar
25
2021
Mexico Provides Food Industry Labeling Flexibility Keller and Heckman LLP
Mar
25
2021
Connecticut District Court Rejects Medical Marijuana User’s ADA Claims Wiggin and Dana LLP
Mar
25
2021
CBD Regulatory Enforcement Continues with Over-the-Counter CBD Pain Relief Products Mintz
Mar
25
2021
Generic Competition for Withdrawn Drug Products Proskauer Rose LLP
Mar
25
2021
Merger Reviews Likely to Address More Expansive—and Possibly New—Theories of Harm Epstein Becker & Green, P.C.
Mar
24
2021
Utah Law Requires Cage-Free Systems by 2025 Keller and Heckman LLP
Mar
23
2021
First Cannabis-Related Business SARS Penalty Against a Depository Institution K&L Gates
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins